INS and metabolic disease: In metabolic diseases like obesity, microglial dysfunction disrupts the inhibitory/excitatory balance of AgRP-pancreatic neural projections, leading to abnormal insulin secretion—an effect that complements the metabolic dysregulation caused by HPA axis dysfunction.